Pharmacy Report Archives - Page 4 of 152 - Becker's Hospital Review

Hospitals push for upfront Medicare drug pricing | AstraZeneca ends lung cancer drug trial | 7 pharmacy leadership moves to know | La. changes PBM reimbursement | 6 big pharma moves

Plus: FDA approves new class of multiple myeloma drug August 18, 2026 1. Hospitals push CMS to ditch 340B rebate model for Medicare drug price negotiation Full story 2. 7 pharmacy leadership moves to know Full story 3. Integrating nonopioid pain…

4 new drugs in shortage | Court rejects pharmacy residents' lawsuit | AstraZeneca opens new 340B legal front | Henry Ford CPO elected ASHP leader | Norton opens $30M central-fill pharmacy

Plus: 250 hospitals with 5 CMS stars for patient experience August 17, 2026 1. 4 new drugs in shortage Full story 2. Judge tosses pharmacy residents’ suit over residency matching system Full story 3. WVU Medicine’s CPO weighs in on expanding…

Drug prices see sharpest drop in 60+ years | 7 deaths spark Prader-Willi drug safety concerns | Employers' big PBM use declines | 10 systems seeking pharmacy leaders | US News' top GLP-1 platforms

Plus: 1 in 5 denied Medicare cancer drug appeals overturned August 13, 2026 1. Prescription drug prices post steepest annual drop since 1963 Full story 2. Clinicians flag safety concerns for Prader-Willi drug after 7 deaths Full story 3. Integrating…

Lilly sues over retatrutide sales | Inside a system's fast specialty pharmacy launch | FDA rejects rival to Novartis cancer therapy | Hims & Hers to sell compounded peptides | Why AstraZeneca's $400B Bristol Myers deal collapsed

Plus: 3 big questions surrounding Trump’s childhood vaccine order August 12, 2026 1. How one system launched a specialty pharmacy in 6 months Full story 2. Lilly sues 6 companies over alleged retatrutide sales Full story 3. How are hospitals…

The court fights putting 340B in limbo | 8 top hospital pharmacies | 8 GLP-1 updates | FDA extends drug-tracking exemptions | Prescription spending shifts: 5 notes

Plus: Trump orders childhood vaccine overhaul August 11, 2026 1. What separates 8 hospital pharmacies from the rest of the country Full story 2. Court battles leaving the 340B program in legal limbo Full story 3. Cottage Health + Sinai…

340B legislation advances in DC | NY hospital has 1st 'age-friendly' pharmacy | Court backs Lilly, Novo in GLP-1 antitrust fight | FDA OKs melanoma therapy, 1st narcolepsy type 1 drug

Plus: Michigan Medicine taps new pharmacy leader August 10, 2026 1. Congress advances new wave of 340B legislation: What to know Full story 2. New York hospital earns nation’s 1st age-friendly pharmacy designation Full story 3. Traditional training moves teams…

Meet the CPOs of US News' Best Hospitals | 340B cuts threaten hospital margins | CMS to share GLP-1 Bridge data | Lilly widens lead over Novo | 10 systems seeking pharmacy leaders

Plus: FDA OKs Modern’s mRNA flu shot August 6, 2026 1. Meet the CPOs of US News’ Best Hospitals Full story 2. CMS to begin sharing GLP-1 Bridge utilization data with Part D plans Full story 3. Traditional training moves teams…

Patients' biggest pharmacy priorities | Hospitals cite patient harm from drug shortages | GLP-1s and pregnancy: What to know | Nation's 2nd public extended PharmD program to launch | CVS revamps GLP-1 program

Plus: 1 in 6 prescribed medications restarted after discharge August 5, 2026 1. What patients want now: 17 pharmacy leaders weigh in Full story 2. Hospitals cite patient harm from injectable drug shortages: 6 notes Full story 3. 3 health…

Lilly expands access to blockbuster obesity drug | GLP-1 coverage cuts reshape pharmacy | 4 health plans rethink specialty pharmacy | Oil prices threaten drug costs | Cleveland Clinic launches drone Rx delivery

Plus: Pharmacy school placed on accreditation probation August 4, 2026 1. Eli Lilly lets physicians request access to its most powerful obesity drug Full story 2. How 4 health plans are innovating with specialty pharmacy Full story 3. Traditional training moves…

340B rebate fight reignites | 9 new drug shortages | Pharma megamerger in the works? | Eli Lilly insulin pricing probe revived | Polypharmacy raises mortality 38%: 4 notes

Plus: Possible GLP-1 treatment for alcohol use disorder August 3, 2026 1. HRSA revises 340B rebate pilot program, hospital groups push back Full story 2. 9 new drugs in shortage Full story 3. 3 health systems share how they centralized…